Oct 29, 2019 / 04:00PM GMT
John L. Lubniewski - HTG Molecular Diagnostics, Inc. - President, CEO & Director
All right. I think we're going to get going. Sorry for the fan noise, we're trying to get that turned off right now. But -- so first of all, I'd like to welcome everyone here and also everyone on the webcast. My name is John Lubniewski, I'm the President and the CEO of HTG Molecular. I'm joined by my colleagues, Dr. Maureen Cronin, who is our Chief Science Officer; Laura Beggrow, who is our President of Diagnostics; and our special guest, Dr. Adam Brufsky from the University of Pittsburgh, School of Medicine. So thank you Dr. Brufsky. Safe harbor.
Here is our program. I'm going to open with a few words about HTG and our overall business and then I'm going to detail our initial initiatives in breast cancer. Hopefully, you'll find it exciting. I think you're going to find this as somewhat breakthrough thinking in regards to diagnostics. And then I'm going to introduce Dr. Brufsky who will present his perspective on breast cancer testing and then we'll open up the floor for questions.
So with that, I'd like
HTG Molecular Diagnostics, Inc. - Special Call Transcript
Oct 29, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers